NCT07128446

Brief Summary

COPM-Based Goal Setting Strategies in the PICU

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started Aug 2025

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Aug 2025Dec 2026

First Submitted

Initial submission to the registry

August 13, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 19, 2025

Completed
10 days until next milestone

Study Start

First participant enrolled

August 29, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

March 10, 2026

Status Verified

August 1, 2025

Enrollment Period

1.3 years

First QC Date

August 13, 2025

Last Update Submit

March 9, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Consensus Level for COPM Implementation Criteria in the PICU (Delphi Survey)

    Level of expert consensus on specific clinical and procedural criteria for implementing COPM-based goal-setting in PICU, measured via a two-round online Delphi survey. Consensus is defined as ≥70% agreement (≥6/10 on a Likert scale) and mean score ≥7 for Likert items, or ≥50% selection for categorical items.

    From initial Delphi invitation to completion of second round (estimated 2-3 weeks).

Secondary Outcomes (2)

  • Client-Centredness of Goal Setting (C-COGS)

    Immediately after pilot intervention completion.

  • Caregiver Perceived Acceptability and Feasibility of COPM-Based Goal Setting in PICU

    Immediately after pilot intervention completion.

Study Arms (1)

Standard physical and occupational therapy

EXPERIMENTAL

Participants will receive standard physiacal and occupational therapy as routinely provided in the PICU. The therapy may include activities of daily living training, positioning, range of motion exercises, and caregiver education, according to each patient's condition. No experimental intervention is introduced; the study focuses on evaluating patient-centered outcomes using the Canadian Occupational Performance Measure.

Other: Standard physical and occupational therapy

Interventions

Participants admitted to the Pediatric Intensive Care Unit (PICU) will receive standard occupational therapy as part of routine clinical care. Interventions will be tailored to each patient's medical status and functional needs and may include activities of daily living (ADL) training, positioning, range of motion exercises, sensory stimulation, and caregiver education. No additional experimental treatment will be introduced for study purposes. The primary focus of the study is to evaluate patient-centered outcomes using the Canadian Occupational Performance Measure (COPM), without altering the standard therapeutic approach.

Standard physical and occupational therapy

Eligibility Criteria

Age1 Year - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Phase 1-2 (Delphi Survey - Experts)
  • Physicians specializing in pediatrics or physical medicine and rehabilitation, occupational therapists, physical therapists, and nursing staff
  • Minimum of 2 years of direct clinical experience in a Pediatric Intensive Care Unit (PICU)
  • Phase 3 (Pilot Testing - Caregivers \& PICU Clinicians)
  • Caregivers:
  • Legal guardian of a child aged 1-18 years admitted to PICU
  • ≥24 hours post-admission
  • PICU clinicians:
  • \- Treating occupational or physical therapist involved in the child's care during PICU admission

You may not qualify if:

  • Phase 1-2 (Delphi Survey - Experts)
  • Rehabilitation professionals without prior PICU clinical experience
  • Inability to read or respond to Korean-language surveys
  • Phase 3 (Pilot Testing - Caregivers \& PICU Clinicians)
  • Caregivers experiencing severe emotional distress, or deemed inappropriate for participation by the treating clinician
  • Non-Korean-speaking caregivers
  • Refusal or withdrawal of informed consent at any stage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Samsung Medical Center

Seoul, Gangnam-gu, 06351, South Korea

RECRUITING

Samsung Medical Center

Seoul, 06351, South Korea

NOT YET RECRUITING

Related Publications (1)

  • Hwang Y, Kwon JY, Cho J, Choi J. Individualized Goal Setting for Pediatric Intensive Care Unit-Based Rehabilitation Using the Canadian Occupational Performance Measure. Children (Basel). 2023 May 31;10(6):985. doi: 10.3390/children10060985.

MeSH Terms

Conditions

Critical Illness

Interventions

Occupational Therapy

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeutics

Central Study Contacts

JEONG-YI KWON, MD, PHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 13, 2025

First Posted

August 19, 2025

Study Start

August 29, 2025

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

March 10, 2026

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared. The dataset includes sensitive clinical information from PICU patients and their caregivers. Due to concerns about patient privacy, potential re-identification risk, and institutional review boardrestrictions, IPD will be used solely for the purposes defined in the approved protocol and will not be made available for external access.

Locations